New hope drug trial for tough pancreatic cancer halted Mid-Study
Disease control
Terminated
This study tested whether adding an experimental drug called ABTL0812 to standard chemotherapy could better control advanced pancreatic cancer that has spread. It involved 60 adults newly diagnosed with metastatic pancreatic cancer who had not yet received treatment for it. The t…
Phase: PHASE1, PHASE2 • Sponsor: Ability Pharmaceuticals SL • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC